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ABSTRACT
Syntheses of new -aminophosphonates 4a–l were achieved through a one-pot, three-component reaction process (the
Kabachnik-Fields reaction). It involves the reaction with substituted salicylaldehydes, amines and dialkyl/diaryl phosphites
in dry toluene at reflux temperature. The structures of the novel products were established by elemental analyses, IR, 1H, 13C
and 31P NMR and mass spectroscopy. All the title compounds were screened for their antibacterial and antifungal activity. Most
of the compounds exhibited moderate antimicrobial activity.
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1. Introduction
The Kabachnik–Fields reaction is one of the most effective
methods for the synthesis of biologically important α-amino-
phosphonates and has received a great deal of attention in
recent years.1,2 The reason is that α-aminophosphonates are
phosphorus analogues of α-aminocarboxylic acids, and there-
fore exhibit biological importance both in themselves and when
used as building blocks of peptides. The addition of compounds
containing P-H bonds to C-C or C-X double bonds provides a
method for the synthesis of organophosphorus derivatives.
Among phosphorus compounds, (R)-amino phosphonic acids
and their derivatives have received considerable attention in
recent years because they exhibit intriguing biological activi-
ties.3,4 Being considered as (R)-amino acid analogues,5 they
have found widespread use as biologically attractive peptide
mimics which have been employed, for example, as inhibitors of
protease6 and as catalytic antibodies.7 In addition, they have
been used as antibacterial8 and anti-HIV agents.9
These entities have been shown to serve as inhibitors of
GABA-receptors, inhibitors of various proteolytic enzymes,
dialkylglycine decarboxylase, peptide mimetics, antibiotics, and
pharmacological agents, including antitumour and anti-
hypertensive agents.8 Various synthetic methods for α-amino-
phosphonic acids and α-aminophosphonates have been
reported. However, the classical approach of synthesis is the
Kabachnik–Fields reaction, which is a one-pot, three-component
operation with a carbonyl compound, amine and dialkyl
phosphite. An efficient solvent-free and catalyst-free method for
the synthesis of α-aminophosphonates was developed by a
microwave-assisted three-component Kabachnik–Fields reac-
tion involving an aldehyde, amine and dimethyl phosphite.9b
Among the reported literature methods, the Kabachnik–Fields
reaction is one of the most convenient approaches to
α-aminophosphonates. We report herein the syntheses of a
series of new α-aminophosphonates, listed in Table 1. All the
new α-aminophosphonates were screened for their anti-
microbial activity.
2. Results and Discussion
Syntheses of new α-aminophosphonates were accomplished
by the reaction of equimolar quantities of different amines,
substituted salicylaldehydes and diphenyl/diethyl/dimethyl
phosphite in dry toluene at reflux temperature for 8–10 h in
67–80% yield. Xue-Jun Mu et al9b recently reported the synthesis
of α-aminophosphonates up to 98% yield in solvent-free,
catalyst-free and in heterogeneous medium under microwave
irradiation (2 min) conditions. Thin layer chromatography
(TLC) was employed to determine the purity of the products. All
the title compounds 4a–l were readily soluble in polar solvents
and melted in the range of 145–184 °C. It is worth mentioning
that many of the synthesized α-aminophosphonates are novel
compounds and inaccessible to preparation by other methods.
All the structures of the novel synthesized α-aminophos-
phonates 4a–l were established by elemental analysis, infrared
(IR), 1H, 13C and 31P nuclear magnetic resonance (NMR) and mass
spectroscopy.
All the compounds 4a–l showed absorption bands in the
regions 3375–3421, 1235–1295 and 739–769 cm–1 for NH, P=O
and P-C(aliphatic), respectively
10 (see Table 2).
The 1H NMR spectral data of 4a–l are furnished in Table 3. The
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Scheme 1
aromatic protons of α-aminophosphonates showed a complex
multiplet at δ 6.52–8.26 ppm. The P-*C-H proton resonated as a
multiplet at δ 4.00–4.55 ppm due to its coupling with phosphorus
and the neighbouring N-H proton. The N-H proton signal
appeared as a singlet at δ 5.12–5.68 ppm. The OH proton gave a
signal at δ 9.00–10.11 ppm, which was confirmed by D2O
exchange experiments. The proton signal of P-OCH2CH3
showed a multiplet and P-OCH2CH3 showed a triplet at
δ 3.78–4.05 and 1.11–1.56 ppm, respectively. The proton signal of
P-OCH3 resonated as a doublet at δ 3.52–3.74 ppm (
2JPH =
10.4–10.7 Hz).11
There is corresponding duplication of signals of the ethoxy
group in the 13C NMR spectra (Table 4). In fact, the CH3 groups
resonated as two doublets at δ 16.4–18.0 ppm (3JPC = 6.5–6.7 Hz)
and the OCH2 group as two doublets at δ 63.2–64.2 ppm (
2JPC =
8.7 to 8.9 Hz), the P-OCH3 groups also gave two doublets at
δ 56.0–57.6 ppm (2JPC = 7.0 Hz). These values are in agreement
with the literature data.11,12,13a,b,14,15a,b,16 The chiral methine carbon
(CH-P) resonated atδ 46.6–49.5 ppm (d, 1JPC = 148.2–151.0 Hz).
11
31P NMR chemical shifts14,15a,b of these compounds 4a–l
appeared in the region of δ 21.69–24.63 ppm (Table 2). Com-
pounds 4a, 4h and 4j showed two signals each in the region
δ 23.72–25.36 ppm. The magnetic non-equivalence in
organophosphorus esters may be due to restricted rotation at
the phosphorus centre.16 It is also evident that the two methoxy
and the two ethoxy groups which are linked to the phosphorus
atom are not magnetically equivalent in these three compounds
as they gave two different signals (for each group) in the 13C
NMR spectra. The existence of the two isomers is termed intrin-
sic non-equivalence or unequal conformer populations or a
combination of both factors.16
The fast atom bombardment (FAB) mass spectrum of 4c exhib-
ited [M++2Na+] and [M+2]+ in the expected ratio for the pres-
ence of bromine and chlorine atoms (see Table 5). Significant
ions were observed at m/z 625, 563, 501, 346 and 344 correspond-







All the title compounds 4a–l were screened for their antibacte-
rial and antifungal activity. Most of the compounds showed
moderate activity against bacteria and low activity against fungi.
3. Experimental
3.1. General Procedure
Progress of the reaction and purity of the compounds were
monitored by TLC using hexane and ethyl acetate (3:1 by vol-
ume) as eluting system and iodine as visualizing agent. Melting
points were determined in open capillary tubes on a Mel-temp
apparatus and were uncorrected. Microanalysis was performed
at the Indian Institute of Science, Bangalore, India. IR spectra
were recorded in the Environmental Engineering Laboratory,
Sri Venkateswara University, Tirupati. IR spectra (ν in cm–1) were
recorded as pressed KBr discs on a Nicolet 380 FT-IR spectro-
photometer. 1H and 13C NMR spectra were recorded on a Bruker
AMX 400 MHz spectrometer operating at 400 MHz for 1H,
100 MHz for 13C and 161.9 MHz for 31P using DMSO-d6.
31P chemi-
cal shifts were measured relative to 85% H3PO4. Mass spectra
were recorded on a Jeol SX 102 DA/600 mass spectrometer using
argon/xenon (6 kV, 10 mA) as the FAB gas and also using ion
electrospray ionization (ESI) at 70 eV on a Micromass Quattro II
instrument.
3. 2. Synthesis of -Aminophosphonate 4e (Typical
Procedure Used)
A mixture of 5-nitrosalicylaldehyde (0.005 mol), 2,4-dichloro-
aniline (0.005 mol), and diethylphosphite (0.005 mol) in dry
toluene was stirred for 30 min. Then the temperature was raised
to reflux and continued for 8 h. Completion of the reaction
was monitored by TLC analysis. After completion of the reac-
tion, the solvent was removed using a rota-evaporator. The
residue was purified by column chromatography using 60–120
mesh silica gel as adsorbent and hexane and ethyl acetate (3:1 by
volume) as an eluent to afford pureα-aminophosphonate 4e as a
solid.
3.3 Antimicrobial Activity
The compounds were assayed for antibacterial activity against
six registered bacterial isolates, which were obtained from the
NCIM (National Collection of Industrial Microorganisms,
National Chemical Laboratories, Pune 411003, India). The bacte-
ria include Gram positive bacterial isolates Staphylococcus aureus
(NCIM No. 5021, ATCC No. 25923), Escherichia coli (NCIM
No. 2931, ATCC No. 25922) and Pseudomonas aeruginosa (NCIM
No. 5029, ATCC No. 27853), Aspergillus niger and Candida albicans.
These samples are clinical isolates from the Department of Bio-
technology, Sri Venkateswara Institute of Medical Sciences,
Tirupati, India. The bacteria were grown on Hi-media nutrient
agar and sub cultured as needed.
Compounds 4a–l were screened for their antibacterial activity
against Staphylococcus aureus, multi-drug resistant Staphylococcus
aureus, Escherichia coli and Pseudomonas aeruginosa (106 cell mL–1)
by the disc-diffusion method18–20 in nutrient agar medium at
various concentrations (250, 500 µg disc–1) in dimethylforma-
mide (DMF). The solutions were added to each filter disc and
DMF was used as the control. The plates were incubated at 35 °C
and examined for zone of inhibition around each disc after 24 h.
The results were compared with the activity of the standard
antibiotic Penicillin (250 µg disc–1). Their antifungal activity21 was
evaluated against Candida albicans and Asperigillus niger at
concentrations of 250 and 500 µg disc–1. Griseofulvin was used as
the reference compound. Fungal cultures were grown on potato
dextrose broth at 25 °C and finally spore suspension was
adjusted to 105 spores mL–1. Most of the compounds showed
moderate activity against bacteria and low activity against fungi
(Table 6).
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Table 1 Syntheses of new α-aminophosphonates 4a–l.
Compound R R' (OR)2 Compound R R' (OR)2
4a NO2 2,4-Cl2C6H3 C6H5 4g Br 2,4-Cl2C6H3 C2H5
4b NO2 3-NO2C6H4 C6H5 4h Br 3-NO2C6H4 C2H5
4c Br 2,4-Cl2C6H3 C6H5 4i NO2 2,4-Cl2C6H3 CH3
4d Br 3-NO2C6H4 C6H5 4j NO2 C10H7(α) CH3
4e NO2 2,4-Cl2C6H3 C2H5 4k Br 2,4-Cl2C6H3 CH3
4f NO2 3-NO2C6H4 C2H5 4l Br 3-NO2C6H4 CH3
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In conclusion, we have described a convenient and efficient
synthetic protocol for the preparation of some novel
α-aminophosphonate derivatives via a one-pot, three-
component system. This method not only provides an excellent
complement for the synthesis ofα-aminophosphonates, but also
avoids the use of hazardous acids or expensive/toxic Lewis acids
and harsh reaction conditions. Most of the compounds exhibited
moderate activity against bacteria and less activity against fungi.
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Table 3 1H NMR chemical shifts a,b of compounds 4a–l.
Compound Ar-H P-CH N-H P-OCH2CH3/OCH3 P-OCH2CH3 OH
4a 8.22–6.89 (m, 16 H) 4.25–4.15 (m, 1H) 5.43 – – 10.10
4b 8.11–6.52 (m, 17 H) 4.27–4.14 (m, 1H) 5.45 – – 9.99
4c 8.21–6.66 (m, 16H) 4.26–4.18 (m, 1H) 5.42 – – 10.02
4d 8.10–6.63 (m, 17H) 4.27–4.20 (m, 1H) 5.44 – – 10.02
4e 8.25–6.82 (m, 6H) 4.13–4.00 (m, 1H) 5.68 3.98–3.71 (m, 4H) 1.23 (t, 3JP-H = 7.1 Hz, CH3) 9.88
1.04 (t, 3JP-H = 7.1 Hz, CH3)
4f 8.11–6.64 (m, 7H) 4.55–4.22 (m, 1H) 5.52 4.00–3.69 (m, 4H) 1.19 (t, 3JP-H = 7.0 Hz, CH3) 10.10
1.05 (t, 3JP-H = 7.0Hz, CH3)
4g 8.12–6.68 (m, 6H) 4.29–4.17 (m, 1H) 5.51 4.05–3.70 (m, 4H) 1.20 (t, 3JP-H = 7.2 Hz, CH3) 10.11
1.03 (t, 3JP-H = 7.2 Hz, CH3)
4h 8.26–6.84 (m,7 H) 4.12–4.03 (m, 1H) 5.53 4.02–3.74 (m, 4H) 1.32 (t, 3JP-H = 7.1 Hz, CH3) 9.99
1.15 (t, 3JP-H = 7.1 Hz, CH3)
4i 8.10–6.59 (m, 6 H) 4.23–4.10 (m, 1H) 5.23 3.74 (d, 2JP-H = 10.7 Hz, OCH3) – 9.00
3.52 (d, 2JP-H = 10.7 Hz, OCH3)
4j 7.32–6.87 (m, 10H) 4.42–4.20 (m, 1H) 5.22 3.71 (d, 2JP-H = 10.4 Hz, OCH3) – 9.23
3.53 (d, 2JP-H = 10.4 Hz, OCH3)
4k 7.92–7.24 (m, 6H) 4.38–4.21 (m, 1H) 5.12 3.71 (d, 2JP-H = 10.4 Hz, OCH3) – 9.10
3.56 (d, 2JP-H = 10.4 Hz, OCH3)
4l 7.93–6.62 (m, 7H) 4.25–4.15 (m, 1H) 5.19 3.70 (d, 2JP-H = 10.6 Hz, OCH3) – 9.01
3.53 (d, 2JP-H = 10.6 Hz, OCH3)
– No such type of proton present.
a Chemical shift δ/ppm.
b Recorded in DMSO-d6.
Table 4 13C NMR chemical shifts a of compounds 4a, 4b, 4e, 4h and 4l.
Compound Chemical shift/ppm
4a 122.1(C-1), 159.0 (C-2), 116.7 (C-3), 124.3 (C-4), 141.0 (C-5), 123.2 (C-6), 143.0 (C-1'), 125.1 (C-2'), 130.2 (C-3'), 127.5 (C-4'), 127.4 (C-5'),
116.6 (C-6'), 148.4 (C-1''), 120.1 (C-2''&C-6''), 128.4 (C-3''&C-5''), 126.6 (C-4''), 49.5 (d, 1JPC = 148.2 Hz, P-CH).
4b 123.7 (C-1), 157.2 (C-2), 118.2 (C-3), 121.2 (C-4), 148.3 (C-5), 123.7 (C-6), 146.4 (C-1'), 111.3 (C-2'), 148.5 (C-3'), 116.5 (C-4'), 131.7 (C-5'),
122.1 (C-6'), – (C-1''), 121.0 (C-2''&C-6''), 128.3 (C-3''&C-5''), 127.1 (C-4''), 49.2 (d, 1JPC = 149 Hz, P-CH).
4e 125.2 (C-1), 161.0 (C-2), 116.9 (C-3), 133.6 (C-4), 113.1 (C-5), 135.6 (C-6), 141.1 (C-1'), 122.3 (C-2'), 129.6 (C-3'), 124.3 (C-4'), 127.9 (C-5'),
120.2 (C-6'), 64.2 (2JPC = 8.9 Hz, OCH2), 63.8 (
2JPC = 8.9 Hz, OCH2), 17.0 (
3JPC = 6.7 Hz,OCH2CH3), 16.4 (
3JPC = 6.7 Hz,OCH2CH3), 48.7
(d, 1JPC = 150 Hz, P-CH).
4h 123.1 (C-1), 161.4 (C-2), 115.5 (C-3), 120.2 (C-4), 140.7 (C-5), 123.1 (C-6), 136.2 (C-1'), 133.7 (C-2'), 124.1 (C-3'), 112.5 (C-4'), 125.1 (C-5'),
112.0 (C-6'), 63.6 (2JPC = 8.7 Hz, OCH2), 63.2 (
2JPC = 8.7 Hz, OCH2), 18.0 (
3JPC = 6.5 Hz, OCH2CH3), 17.5 (
3JPC = 6.5 Hz, OCH2CH3),
46.6 (d, 1JPC = 151.0 Hz, P-CH).
4l 124.2 (C-1), 160.3 (C-2), 131.1 (C-3), 131.1 (C-4), 115.6 (C-5), 122.1 (C-6), 144.0 (C-1'), 112.6 (C-2'), 148.6 (C-3'), 113.5 (C-4'), 130.3 (C-5'),
121.0 (C-6'), 57.6 (2JPC = 7.0 Hz, OCH3), 56.7 (
2JPC = 7.0 Hz, OCH3), 47.5 (d,
1JPC = 148 Hz, P-CH).
a Recorded in DMSO-d6.
Table 5 FAB a/ESI b mass spectral data of compounds 4c, 4e, 4f and 4l.
Compound (m/z)/%
4c a 625 [(8.3), M++2Na+], 581 [(14.0), M+ +2], 579 [(15.5), M+] 563 (5.5), 503 (58.3), 501 (44.4), 425 (19.4), 408 (6.1), 408 (5.5), 391 (16.7),
346 (100), 344 (83.3), 289(13.9), 261 (8.3), 154 (50.0).
4e a 449 [(80), M+], 431 (8.6), 420 (11.4), 311 (100), 294 (25.7), 265 (41.3), 154 (11.4), 136 (11.4), 120 (2.8), 102 (5.7), 93 (2.8).
4f b 425 [(9.1), M+], 365 (1.8), 334 (2.4), 289 (6.7), 288 (47.1), 227 (6.1), 196 (2.4), 139 (5.4), 74 (100).
4l a 433 [(25.0), M+ +2] 431 [(31.2), M+], 399 (62.5), 309 (46.9), 294 (15.5), 259 (40.6), 109 (100), 62 (78.1).
and helpful discussion and the Director, Indian Institute of
Science, Bangalore, India, for the C, H, N analysis, 1H, 13C, 31P and
mass spectral data.
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Table 6 Antimicrobial activity of new α-aminophosphonates 4a–l; zone of inhibition in mm.
Compound Bacteria Fungi
Staphylococcus Multi drug resistant Escherichia Pseudomonas Candida Aspergillus
aureus Staphylococcus coli aeruginosa albicans niger
aureus
µg disc–1: 250 500 250 500 250 500 250 500 250 500 250 500
4a 12 15 10 12 9.8 11 9.2 13 2 4.8 4 6.3
4b 9 12 9.8 12 10 13.1 9 11 2.8 3.9 4.4 5.9
4c 10 13 8.9 14 11 16 10.1 14.1 3.8 4.1 3.9 5.7
4d 9 14 8.8 15 10.5 13.2 9.9 12.2 4.2 5.2 3.4 6.1
4e 10 13 9.9 13 9.5 12.5 10.5 14.3 2.9 5.5 2.8 5.2
4f 16 20 9.8 11 10 12.3 10.5 13.5 3.2 4.5 2.9 5.2
4g 13 18 10 13 9.6 14.1 10.6 13.6 3.3 4.8 3 5.9
4h 10 13 12 15.1 10.1 13 8.9 13.2 2.2 8.2 3.1 5.6
4i 9 14 9.6 13.2 8.9 12.1 9.1 11.6 3.1 4.3 3.8 5.9
4j 10 12 10 12.3 11.1 14 9 12.9 3 4.9 2.1 4.8
4k 12 15 10 13.1 9.3 13.1 11.1 14.4 3.8 5.3 3.9 5.1
4l 9 11 9 14 11.2 14 10.1 14.3 2 5.2 2 4.3
Penicillin 22 21 21 21
Griseofulvin 20 20
